References

Multivalent lactobionic acid and N-Acetylgalactosamine-Conjugated peptide nucleic acids for efficient in vivo targeting of hepatocytes

10.1002/adhm.202202859 · ExternalCitation · doi-reference

Magnetic iron oxide nanoworms for tumor targeting and imaging

10.1002/adma.200800004 · ExternalCitation · doi-reference

3D cellular architecture affects MicroRNA and protein cargo of extracellular vesicles

10.1002/advs.201800948 · ExternalCitation · doi-reference

Engineering and monitoring the sustained release of extracellular vesicles from hydrogels for in vivo therapeutic applications

10.1002/anbr.202400073 · ExternalCitation · doi-reference

Hydrogels as extracellular matrix mimics for 3D cell culture

10.1002/bit.22361 · ExternalCitation · doi-reference

Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles

10.1002/btm2.10065 · ExternalCitation · doi-reference

Bioprocess optimization using design-of-experiments methodology

10.1002/btpr.67 · ExternalCitation · doi-reference

Immune monitoring in renal transplantation: the search for biomarkers

10.1002/eji.201545963 · ExternalCitation · doi-reference

The role of matrix stiffness in regulating cell behavior

10.1002/hep.22193 · ExternalCitation · doi-reference

Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis

10.1002/hep.23922 · ExternalCitation · doi-reference

Hepatic inflammation and fibrosis: functional links and key pathways

10.1002/hep.27332 · ExternalCitation · doi-reference

A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis

10.1002/hep.29477 · ExternalCitation · doi-reference

Formation of a protein corona on the surface of extracellular vesicles in blood plasma

10.1002/jev2.12140 · ExternalCitation · doi-reference

Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches

10.1002/jev2.12404 · ExternalCitation · doi-reference

Extracellular vesicles from bone marrow-derived mesenchymal stem cells improve survival from lethal hepatic failure in mice

10.1002/sctm.16-0226 · ExternalCitation · doi-reference

Concise review: developing best-practice models for the therapeutic use of extracellular vesicles

10.1002/sctm.17-0055 · ExternalCitation · doi-reference

Concise review: MSC-derived exosomes for cell-free therapy

10.1002/stem.2575 · ExternalCitation · doi-reference

Electroconductive hydrogels for biomedical applications

10.1002/wnan.1568 · ExternalCitation · doi-reference

Chiral fiber supramolecular hydrogels for tissue engineering

10.1002/wnan.1847 · ExternalCitation · doi-reference

Generation of multicellular tumor spheroids by the hanging-drop method

10.1007/978-1-59745-443-8_8 · ExternalCitation · doi-reference

Vsig4(+) resident single-kupffer cells improve hepatic inflammation and fibrosis in NASH

10.1007/s00011-023-01696-1 · ExternalCitation · doi-reference

Process analytical technology (PAT) for biopharmaceutical products

10.1007/s00216-010-3781-x · ExternalCitation · doi-reference

TGF-β in progression of liver disease

10.1007/s00441-011-1246-y · ExternalCitation · doi-reference

Quality and safety considerations for therapeutic products based on extracellular vesicles

10.1007/s11095-024-03757-4 · ExternalCitation · doi-reference

Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication

10.1007/s12195-016-0457-4 · ExternalCitation · doi-reference

Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery

10.1016/j.addr.2012.07.001 · ExternalCitation · doi-reference

Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology

10.1016/j.addr.2013.11.009 · ExternalCitation · doi-reference

Extracellular vesicles for drug delivery

10.1016/j.addr.2016.02.006 · ExternalCitation · doi-reference

Hepatic stellate cells as key target in liver fibrosis

10.1016/j.addr.2017.05.007 · ExternalCitation · doi-reference

Strategic design of extracellular vesicle drug delivery systems

10.1016/j.addr.2018.06.017 · ExternalCitation · doi-reference

Nrf2-Keap1 signaling in oxidative and reductive stress

10.1016/j.bbamcr.2018.02.010 · ExternalCitation · doi-reference

Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia/reperfusion injury

10.1016/j.bbrc.2013.01.015 · ExternalCitation · doi-reference

Extracellular vesicles-in-hydrogel (EViH) targeting pathophysiology for tissue repair

10.1016/j.bioactmat.2024.10.017 · ExternalCitation · doi-reference

A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy

10.1016/j.biomaterials.2013.11.083 · ExternalCitation · doi-reference

Exosomes for drug delivery - a novel application for the mesenchymal stem cell

10.1016/j.biotechadv.2012.08.008 · ExternalCitation · doi-reference

Hippo pathway activity influences liver cell fate

10.1016/j.cell.2014.03.060 · ExternalCitation · doi-reference

Communication by extracellular vesicles: where we are and where we need to Go

10.1016/j.cell.2016.01.043 · ExternalCitation · doi-reference

Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy

10.1016/j.colsurfb.2011.05.013 · ExternalCitation · doi-reference

New advances in exosome-based targeted drug delivery systems

10.1016/j.critrevonc.2022.103628 · ExternalCitation · doi-reference

Review of precision cancer medicine: evolution of the treatment paradigm

10.1016/j.ctrv.2020.102019 · ExternalCitation · doi-reference

The PDGF system and its antagonists in liver fibrosis

10.1016/j.cytogfr.2015.10.002 · ExternalCitation · doi-reference

Adipocytes-derived exosomal miR-122 promotes non-alcoholic fat liver disease progression via targeting Sirt1

10.1016/j.gastrohep.2022.12.003 · ExternalCitation · doi-reference

Protein corona, understanding the nanoparticle-protein interactions and future perspectives: a critical review

10.1016/j.ijbiomac.2020.12.108 · ExternalCitation · doi-reference

Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection

10.1016/j.ijcard.2014.12.043 · ExternalCitation · doi-reference

Preservation of exosomes at room temperature using lyophilization

10.1016/j.ijpharm.2018.10.032 · ExternalCitation · doi-reference

Macrophages in tissue repair, regeneration, and fibrosis

10.1016/j.immuni.2016.02.015 · ExternalCitation · doi-reference

Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p/SLIT3 axis

10.1016/j.intimp.2023.111134 · ExternalCitation · doi-reference

Visualization and in vivo tracking of the exosomes of murine melanoma B16-BL6 cells in mice after intravenous injection

10.1016/j.jbiotec.2013.03.013 · ExternalCitation · doi-reference

Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles

10.1016/j.jconrel.2013.08.014 · ExternalCitation · doi-reference

Extracellular vesicles as drug delivery systems: lessons from the liposome field

10.1016/j.jconrel.2014.07.049 · ExternalCitation · doi-reference

Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications

10.1016/j.jconrel.2015.02.022 · ExternalCitation · doi-reference

Anti-PEG IgM production and accelerated blood clearance phenomenon after the administration of PEGylated exosomes in mice

10.1016/j.jconrel.2021.05.001 · ExternalCitation · doi-reference

Injectable hydrogels for sustained delivery of extracellular vesicles in cartilage regeneration

10.1016/j.jconrel.2023.01.060 · ExternalCitation · doi-reference

MSC-derived exosomes injectable hyaluronic acid hydrogel for enhanced chronic wound healing

10.1016/j.jconrel.2025.113985 · ExternalCitation · doi-reference

Critical considerations for the development of potency tests for therapeutic applications of mesenchymal stromal cell-derived small extracellular vesicles

10.1016/j.jcyt.2021.01.001 · ExternalCitation · doi-reference

Overcoming challenges in MSC-sEV therapeutics: insights and advances after a decade of research

10.1016/j.jcyt.2025.03.505 · ExternalCitation · doi-reference

Macrophage heterogeneity in liver injury and fibrosis

10.1016/j.jhep.2013.12.025 · ExternalCitation · doi-reference

The hippo pathway effector YAP controls mouse hepatic stellate cell activation

10.1016/j.jhep.2015.04.011 · ExternalCitation · doi-reference

Pretreatment of exosomes derived from hUCMSCs with TNF-α ameliorates acute liver failure by inhibiting the activation of NLRP3 in macrophage

10.1016/j.lfs.2020.117401 · ExternalCitation · doi-reference

Secreted monocytic miR-150 enhances targeted endothelial cell migration

10.1016/j.molcel.2010.06.010 · ExternalCitation · doi-reference

Ultrafiltration with size-exclusion liquid chromatography for high yield isolation of extracellular vesicles preserving intact biophysical and functional properties

10.1016/j.nano.2015.01.003 · ExternalCitation · doi-reference

Higher functionality of extracellular vesicles isolated using size-exclusion chromatography compared to ultracentrifugation

10.1016/j.nano.2017.03.011 · ExternalCitation · doi-reference

Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: new nanotools for cancer treatment

10.1016/j.phrs.2016.07.006 · ExternalCitation · doi-reference

Basic points to consider regarding the preparation of extracellular vesicles and their clinical applications in Japan

10.1016/j.reth.2022.05.003 · ExternalCitation · doi-reference

MSC exosome as a cell-free MSC therapy for cartilage regeneration: implications for osteoarthritis treatment

10.1016/j.semcdb.2016.11.008 · ExternalCitation · doi-reference

MSC-Based product characterization for clinical trials: an FDA perspective

10.1016/j.stem.2014.01.013 · ExternalCitation · doi-reference

Mesenchymal stromal cells: clinical challenges and therapeutic opportunities

10.1016/j.stem.2018.05.004 · ExternalCitation · doi-reference

Secreted microRNAs: a new form of intercellular communication

10.1016/j.tcb.2011.12.001 · ExternalCitation · doi-reference

Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity

10.1016/j.tox.2005.07.023 · ExternalCitation · doi-reference

hucMSC exosome-derived GPX1 is required for the recovery of hepatic oxidant injury

10.1016/j.ymthe.2016.11.019 · ExternalCitation · doi-reference

Exosomes produced from 3D cultures of MSCs by tangential flow filtration show higher yield and improved activity

10.1016/j.ymthe.2018.09.015 · ExternalCitation · doi-reference

Hydrogels for tissue engineering: scaffold design variables and applications

10.1016/s0142-9612(03)00340-5 · ExternalCitation · doi-reference

Hydrogel-mediated sustained systemic delivery of mesenchymal stem cell-derived extracellular vesicles improves hepatic regeneration in chronic liver failure

10.1021/acsami.9b10126 · ExternalCitation · doi-reference

Hydrogel loaded with aminoethyl anisamide-modified exosomes attenuates hepatic fibrosis by targeting activated hepatic stellate cells

10.1021/acsnano.5c06003 · ExternalCitation · doi-reference

Surface functionalization of exosomes using click chemistry

10.1021/bc500291r · ExternalCitation · doi-reference

Emerging frontiers in drug delivery

10.1021/jacs.5b09974 · ExternalCitation · doi-reference

Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases

10.1038/emm.2017.63 · ExternalCitation · doi-reference

MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease

10.1038/leu.2014.41 · ExternalCitation · doi-reference

Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation

10.1038/mt.2011.189 · ExternalCitation · doi-reference

Mesenchymal stem cells deliver exogenous MicroRNA-let7c via exosomes to attenuate renal fibrosis

10.1038/mt.2016.90 · ExternalCitation · doi-reference

Designing materials for biology and medicine

10.1038/nature02388 · ExternalCitation · doi-reference

Role of YAP/TAZ in mechanotransduction

10.1038/nature10137 · ExternalCitation · doi-reference

Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer

10.1038/nature22341 · ExternalCitation · doi-reference

Quality cell therapy manufacturing by design

10.1038/nbt.3525 · ExternalCitation · doi-reference

Quality by design for biopharmaceuticals

10.1038/nbt0109-26 · ExternalCitation · doi-reference

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

10.1038/ncb1596 · ExternalCitation · doi-reference

Rab27a and Rab27b control different steps of the exosome secretion pathway

10.1038/ncb2000 · ExternalCitation · doi-reference

Mechanisms of fibrosis: therapeutic translation for fibrotic disease

10.1038/nm.2807 · ExternalCitation · doi-reference

A practical guide to hydrogels for cell culture

10.1038/nmeth.3839 · ExternalCitation · doi-reference

EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research

10.1038/nmeth.4185 · ExternalCitation · doi-reference

Immunological properties of engineered nanomaterials

10.1038/nnano.2007.223 · ExternalCitation · doi-reference

Biomolecular coronas provide the biological identity of nanosized materials

10.1038/nnano.2012.207 · ExternalCitation · doi-reference

Extracellular vesicles: biology and emerging therapeutic opportunities

10.1038/nrd3978 · ExternalCitation · doi-reference

Immunology in the liver--from homeostasis to disease

10.1038/nrgastro.2015.200 · ExternalCitation · doi-reference

Mechanisms of hepatic stellate cell activation

10.1038/nrgastro.2017.38 · ExternalCitation · doi-reference

Liver macrophages in tissue homeostasis and disease

10.1038/nri.2017.11 · ExternalCitation · doi-reference

Protective and pathogenic functions of macrophage subsets

10.1038/nri3073 · ExternalCitation · doi-reference

Extracellular vesicle-based therapeutics: natural versus engineered targeting and trafficking

10.1038/s12276-019-0223-5 · ExternalCitation · doi-reference

Clinical implications of exosome-derived noncoding RNAs in liver

10.1038/s41374-021-00723-1 · ExternalCitation · doi-reference

Designer exosomes produced by implanted cells intracerebrally deliver therapeutic cargo for Parkinson's disease treatment

10.1038/s41467-018-03733-8 · ExternalCitation · doi-reference

Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip

10.1038/s41551-019-0356-9 · ExternalCitation · doi-reference

Extracellular vesicles as a next-generation drug delivery platform

10.1038/s41565-021-00931-2 · ExternalCitation · doi-reference

Cellular uptake and in vivo distribution of mesenchymal-stem-cell-derived extracellular vesicles are protein corona dependent

10.1038/s41565-023-01585-y · ExternalCitation · doi-reference

Apoptosis and necroptosis in the liver: a matter of life and death

10.1038/s41575-018-0065-y · ExternalCitation · doi-reference

Gene regulation by long non-coding RNAs and its biological functions

10.1038/s41580-020-00315-9 · ExternalCitation · doi-reference

RNA delivery by extracellular vesicles in mammalian cells and its applications

10.1038/s41580-020-0251-y · ExternalCitation · doi-reference

Resolving the fibrotic niche of human liver cirrhosis at single-cell level

10.1038/s41586-019-1631-3 · ExternalCitation · doi-reference

Effects of extracellular matrix viscoelasticity on cellular behaviour

10.1038/s41586-020-2612-2 · ExternalCitation · doi-reference

Engineering hybrid exosomes by membrane fusion with liposomes

10.1038/srep21933 · ExternalCitation · doi-reference

Trehalose prevents aggregation of exosomes and cryodamage

10.1038/srep36162 · ExternalCitation · doi-reference

Designing TIMP (tissue inhibitor of metalloproteinases) variants that are selective metalloproteinase inhibitors

10.1042/bss0700201 · ExternalCitation · doi-reference

Deactivation of hepatic stellate cells during liver fibrosis resolution in mice

10.1053/j.gastro.2012.06.036 · ExternalCitation · doi-reference

β-Catenin signaling and roles in liver homeostasis, injury, and tumorigenesis

10.1053/j.gastro.2015.02.056 · ExternalCitation · doi-reference

Balancing safety and innovation for cell-based regenerative medicine

10.1056/nejmsr1715626 · ExternalCitation · doi-reference

Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis

10.1073/pnas.1119964109 · ExternalCitation · doi-reference

Self-assembled PEGylated albumin nanoparticles (SPAN) as a platform for cancer chemotherapy and imaging

10.1080/10717544.2018.1489430 · ExternalCitation · doi-reference

Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement

10.1080/14653240600855905 · ExternalCitation · doi-reference

Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines

10.1080/20013078.2018.1535750 · ExternalCitation · doi-reference

Extracellular vesicles or exosomes? On primacy, precision, and popularity influencing a choice of nomenclature

10.1080/20013078.2019.1648167 · ExternalCitation · doi-reference

Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats

10.1089/neu.2017.5063 · ExternalCitation · doi-reference

Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis

10.1089/scd.2012.0395 · ExternalCitation · doi-reference

Exosomes derived from bone marrow mesenchymal stem cells as treatment for severe COVID-19

10.1089/scd.2020.0080 · ExternalCitation · doi-reference

Mesenchymal stem cells for therapeutic purposes

10.1097/tp.0b013e3181a28635 · ExternalCitation · doi-reference

Immunomodulatory properties and therapeutic application of mesenchymal stem cells

10.1111/j.1365-2249.2011.04327.x · ExternalCitation · doi-reference

MiR-122 modification enhances the therapeutic efficacy of adipose tissue-derived mesenchymal stem cells against liver fibrosis

10.1111/jcmm.13208 · ExternalCitation · doi-reference

Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases

10.1126/sciadv.abp9435 · ExternalCitation · doi-reference

Ceramide triggers budding of exosome vesicles into multivesicular endosomes

10.1126/science.1153124 · ExternalCitation · doi-reference

The biology, function, and biomedical applications of exosomes

10.1126/science.aau6977 · ExternalCitation · doi-reference

EASL clinical practice guidelines: non-invasive liver tests for evaluation of liver disease severity and prognosis

10.1136/flgastro-2021-102064 · ExternalCitation · doi-reference

Hydrogel-tissue chemistry: principles and applications

10.1146/annurev-biophys-070317-032905 · ExternalCitation · doi-reference

Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles

10.1146/annurev-cellbio-101512-122326 · ExternalCitation · doi-reference

RGD and other recognition sequences for integrins

10.1146/annurev.cellbio.12.1.697 · ExternalCitation · doi-reference

Hepatic stellate cells require a stiff environment for myofibroblastic differentiation

10.1152/ajpgi.00412.2010 · ExternalCitation · doi-reference

Clinical advancements in the targeted therapies against liver fibrosis

10.1155/2016/7629724 · ExternalCitation · doi-reference

Mesenchymal stromal cells: from discovery to manufacturing and commercialization

10.1155/2018/4083921 · ExternalCitation · doi-reference

Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair

10.1172/jci22675 · ExternalCitation · doi-reference

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

10.1172/jci30542 · ExternalCitation · doi-reference

Liver inflammation and fibrosis

10.1172/jci88881 · ExternalCitation · doi-reference

Hypoxic enhancement of exosome release by breast cancer cells

10.1186/1471-2407-12-421 · ExternalCitation · doi-reference

Recent advancements in the use of exosomes as drug delivery systems

10.1186/s12951-018-0403-9 · ExternalCitation · doi-reference

Huc-MSCs-derived exosomes attenuate inflammatory pain by regulating microglia pyroptosis and autophagy via the miR-146a-5p/TRAF6 axis

10.1186/s12951-022-01522-6 · ExternalCitation · doi-reference

Exosomal miR-499a-5p from human umbilical cord mesenchymal stem cells attenuates liver fibrosis via targeting ETS1/GPX4-mediated ferroptosis in hepatic stellate cells

10.1186/s12951-025-03291-4 · ExternalCitation · doi-reference

Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery

10.1186/s12951-025-03654-x · ExternalCitation · doi-reference

Mesenchymal stromal cell-derived extracellular vesicles therapy openings new translational challenges in immunomodulating acute liver inflammation

10.1186/s12967-024-05282-9 · ExternalCitation · doi-reference

Engineered exosomes from umbilical cord mesenchymal stem cells with pPB modification attenuate hepatic fibrosis via hepatic stellate cell targeting

10.1186/s12967-025-07658-x · ExternalCitation · doi-reference

Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway

10.1186/s13287-019-1204-2 · ExternalCitation · doi-reference

Mesenchymal stem cell-based cell-free strategies: safe and effective treatments for liver injury

10.1186/s13287-020-01895-1 · ExternalCitation · doi-reference

Mesenchymal stem cell-derived exosomes as cell-free therapeutics: mechanistic insights and engineering strategies for liver disease treatment

10.1186/s13287-025-04747-y · ExternalCitation · doi-reference

Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models

10.1186/scrt465 · ExternalCitation · doi-reference

Preservation and storage stability of extracellular vesicles for therapeutic applications

10.1208/s12248-017-0160-y · ExternalCitation · doi-reference

Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells

10.1634/stemcells.2005-0008 · ExternalCitation · doi-reference

Extracellular vesicles: emerging therapeutic agents for liver fibrosis

10.20517/evcna.2025.08 · ExternalCitation · doi-reference

MISEV and MIQE: integrating domain-specific and general standards to strengthen extracellular vesicle biomarker research

10.20517/evcna.2025.68 · ExternalCitation · doi-reference

Exosome mimetics: a novel class of drug delivery systems

10.2147/ijn.s29661 · ExternalCitation · doi-reference

The translation of cell-based therapies: clinical landscape and manufacturing challenges

10.2217/rme.14.73 · ExternalCitation · doi-reference

Strategies to improve the therapeutic efficacy of mesenchymal stem cell-derived extracellular vesicle (MSC-EV): a promising cell-free therapy for liver disease

10.3389/fbioe.2023.1322514 · ExternalCitation · doi-reference

Scalable production of human mesenchymal stromal cell-derived extracellular vesicles under Serum-/Xeno-Free conditions in a microcarrier-based bioreactor culture system

10.3389/fcell.2020.553444 · ExternalCitation · doi-reference

Extracellular vesicles as advanced therapeutics for the resolution of organ fibrosis: current progress and future perspectives

10.3389/fimmu.2022.1042983 · ExternalCitation · doi-reference

To protect and to preserve: novel preservation strategies for extracellular vesicles

10.3389/fphar.2018.01199 · ExternalCitation · doi-reference

Extracellular vesicles as promising carriers in drug delivery: considerations from a cell biologist's perspective

10.3390/biology10050376 · ExternalCitation · doi-reference

A new perspective on regenerative medicine: plant-derived extracellular vesicles

10.3390/biom15081095 · ExternalCitation · doi-reference

Tangential flow filtration for highly efficient concentration of extracellular vesicles from large volumes of fluid

10.3390/cells7120273 · ExternalCitation · doi-reference

Manufacturing of human extracellular vesicle-based therapeutics for clinical use

10.3390/ijms18061190 · ExternalCitation · doi-reference

Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine

10.3390/ijms18091852 · ExternalCitation · doi-reference

Existing and novel biomaterials for bone tissue engineering

10.3390/ijms24010529 · ExternalCitation · doi-reference

Procoagulant activity of umbilical cord-derived mesenchymal stromal cells' extracellular vesicles (MSC-EVs)

10.3390/ijms24119216 · ExternalCitation · doi-reference

Mitochondrial dysfunction in metabolic dysfunction fatty liver disease (MAFLD)

10.3390/ijms242417514 · ExternalCitation · doi-reference

Clinical applications of exosomes: a critical review

10.3390/ijms25147794 · ExternalCitation · doi-reference

Exosomes and exosome-inspired vesicles for targeted drug delivery

10.3390/pharmaceutics10040218 · ExternalCitation · doi-reference

Harnessing extracellular vesicles for targeted drug delivery in ovarian cancer

10.3390/pharmaceutics17040528 · ExternalCitation · doi-reference

Single-step isolation of extracellular vesicles by size-exclusion chromatography

10.3402/jev.v3.23430 · ExternalCitation · doi-reference

Effect of storage on physical and functional properties of extracellular vesicles derived from neutrophilic granulocytes

10.3402/jev.v3.25465 · ExternalCitation · doi-reference

Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for extracellular vesicles

10.3402/jev.v3.26913 · ExternalCitation · doi-reference

Macrophage-dependent clearance of systemically administered B16BL6-derived exosomes from the blood circulation in mice

10.3402/jev.v4.26238 · ExternalCitation · doi-reference

Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting

10.3402/jev.v4.26316 · ExternalCitation · doi-reference

Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper

10.3402/jev.v4.30087 · ExternalCitation · doi-reference

Lyoprotectant constituents suited for lyophilization and reconstitution of stem-cell-derived extracellular vesicles

10.34133/bmr.0005 · ExternalCitation · doi-reference

Hurdles to overcome for mesenchymal stem cell translation from bench to bedside

10.4252/wjsc.v17.i12.114349 · ExternalCitation · doi-reference

Integrative bioengineering strategies for endometrial regeneration: from biomaterials and stem cells to organoids and organ-on-a-chip technologies

10.7150/thno.123298 · ExternalCitation · doi-reference

Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo chronic myelogenous Leukemia cell growth

10.7150/thno.17092 · ExternalCitation · doi-reference